Age is not a contraindication to pancreaticoduodenectomy

Hodul, Pamela; Tansey, Joseph; Golts, Eugene; Oh, Daniel; Pickleman, Jack; Aranha, Gerard V.; Hodul, P; Tansey, J; Golts, E; Oh, D; Pickleman, J; Aranha, G V
March 2001
American Surgeon;Mar2001, Vol. 67 Issue 3, p270
Academic Journal
journal article
The incidence of pancreatic cancer has increased threefold over the last 40 years with the greatest rate of growth occurring in the elderly. In the past it was suggested that elderly patients tolerated pancreaticoduodenectomy less well than younger patients with higher mortality rates. This single-institution experience examines the question of whether age is a significant factor in relation to morbidity and mortality in patients undergoing pancreaticoduodenectomy. Between 1994 and 1999 outcomes of 122 patients who underwent pancreaticoduodenectomy were reviewed. There were 48 patients 70 years of age and older and 74 patients less than 70 years of age. Both groups were compared with respect to preoperative clinical prognostic determinates and perioperative factors affecting morbidity and mortality. There was no significant difference between the two groups comparing their comorbidities, use of preoperative antibiotics, intraoperative blood loss, or length of hospital stay (11.9 and 10.8 days respectively). The two groups were also similar with regard to pathologic diagnosis with pancreatic adenocarcinoma being the most frequently encountered neoplasm. There was one death in the less-than-70-year-old group and none in the older group. No significant difference in the rate of complications was appreciated. These data demonstrate that pancreaticoduodenectomy can be performed safely in patients 70 years of age and older with morbidity and mortality rates similar to those of younger individuals.


Related Articles

  • Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer. Kishi, Y.; Nara, S.; Esaki, M.; Hiraoka, N.; Shimada, K. // BJS Open;Jun2019, Vol. 3 Issue 3, p327 

    Background: Whether the portal/superior mesenteric vein (PV) should be resected during pancreatoduodenectomy for pancreatic ductal adenocarcinoma (PDAC) based on preoperative CT or intraoperative findings is controversial. Methods: This was a retrospective study with data of patients who had...

  • Pancreas.  // Gut;Jul2012 Supplement, Vol. 61, pA112 

    The article presents abstracts on medical topics in Great Britain which include pancreatic cancer, the oncological outcomes of the laparoscopic pancreaticoduodenectomy and the use of endoscopic retrograde cholangiopancreatography for the biopsies of patients.

  • Laparoscopic Staging and Surgical Treatment of Pancreatic Cancer. Muniraj, Thiruvengadam; Barve, Pranav // North American Journal of Medical Sciences;Jan2013, Vol. 5 Issue 1, p1 

    Pancreatic cancer is the tenth most common cancer and the fourth leading cause of cancer deaths in the United States. Surgery remains a cornerstone in the treatment of pancreatic cancer. Unfortunately, the percentage of patients presenting at the resectable stage is minimal. Although computed...

  • Pancreatic Cancer. Funel, Niccola; Del Chiaro, Marco; Cahen, Djuna L.; Laukkarinen, Johanna // Gastroenterology Research & Practice;3/24/2015, Vol. 2015, p1 

    No abstract available.

  • Colloid (mucinous non-cystic) carcinoma of the pancreas: A case report. YANG GAO; YA-YUN ZHU; ZHOU YUAN // Oncology Letters;Nov2015, Vol. 10 Issue 5, p3195 

    Colloid carcinoma (CC) of the pancreas, also known as mucinous non-cystic carcinoma, is a rare histological variant of pancreatic cancer. The present study reports the case of a 65-year-old male with a pancreatic head tumor 4.6x3.1 cm in size. The tumor had not invaded the superior mesenteric or...

  • The impact of surgical resection margins on survival of patients with pancreatic ductal adenocarcinoma. Shah, Sundip; Kruper, Tanya; Driman, David; Leslie, Ken // Canadian Journal of Pathology;2018 Supplement, Vol. 10, p21 

    Pancreaticoduodenectomy also known as a Whipple's procedure is a complex operation that involves the removal of the head of pancreas, duodenum, common bile duct, gallbladder and sometimes a portion of stomach. It is used as a treatment option for patients with biliary, pancreatic and duodenal...

  • Minimally Invasive Surgery for Pancreatic Disease - Current Status. Alsfasser, G.; Hermeneit, S.; Rau, B.M.; Klar, E. // Digestive Surgery;May2016, Vol. 33 Issue 4, p276 

    Laparoscopic procedures have advanced to represent the new gold standard in many surgical fields. Although application in pancreatic surgery is hampered by the friable nature of the gland and the difficulty of its exposure, advanced technology and surgeons' experience are leading to an expansion...

  • Evolução histórica do tratamento cirúrgico do câncer de pâncreas. Garcia Toneto, Marcelo; Itaqui Lopes, Maria Helena // Scientia Medica;abr-jun2014, Vol. 24 Issue 2, p1 

    AIMS: To review the main historical aspects of the evolution of the treatment of pancreatic cancer. SOURCE OF DATA: Literature review through PubMed. Selected articles on the history of the treatment of pancreatic cancer were analyzed. SUMMARY OF FINDINGS: Complete surgical resection is the only...

  • How to Counter the Problem of R1 Resection in Duodenopancreatectomy for Pancreatic Cancer? Angst, Eliane; Kim-Fuchs, Corina; Chittazhathu Kurian Kuruvilla, Yojena; Inderbitzin, Daniel; Montani, Matteo; Candinas, Daniel; Gloor, Beat // Journal of Gastrointestinal Surgery;Mar2012, Vol. 16 Issue 3, p673 

    Objective: Although duodenopancreatectomy has been standardized for many years, the pathological examination of the specimen was re-described in the last years. In methodical pathological studies up to 85% had an R1 margin., These mainly involved the posterior und medial resection margin. As a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics